tirzepatide 11mg Compounded for Weight Management RemedyMeds
Description
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Temperature fluctuations during handling, brief exposure to warmth when drawing doses, and agitation all contribute to peptide degradation over time
The medication's mechanism of action directly impacts gastrointestinal function, which explains why digestive side effects, including sulfur burps, occur in some patients
Yet some Mounjaro patients report vomiting several times a day for two weeks or more
the most common were nausea, diarrhea, constipation and vomiting
